Defect-related luminescent nanostructured hydroxyapatite promotes mineralization through both intracellular and extracellular pathways by Dai, Chunyan et al.
RSC Advances
PAPER
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
14
/2
01
9 
2:
32
:2
6 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e. View Article Online
View Journal  | View IssueDefect-related luaKey Laboratory of Tropical Medicinal Pla
Hainan Normal University, Haikou 57115
163.com; chgying123@163.com
bDepartment of Chemistry, University of War
haddleton@warwick.ac.uk
Cite this: RSC Adv., 2019, 9, 35939
Received 22nd August 2019
Accepted 10th October 2019
DOI: 10.1039/c9ra06629b
rsc.li/rsc-advances
This journal is © The Royal Society of Cminescent nanostructured
hydroxyapatite promotes mineralization through
both intracellular and extracellular pathways
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Hydroxyapatite (HAP) is a widely used biomaterial for bone tissue substitution due to its chemical similarity
with the natural bone. Defect-related luminescent HAP materials have the same chemical composition as
normal HAP and excellent biocompatibility. However, only few works have focused on the defect-related
luminescent HAP materials on bone regeneration. In this work, we systematically investigated the bone
regeneration pathway induced by nanostructured particles using defect-related luminescent
hydroxyapatite (S2) materials. We monitored the subcellular distribution and location of S2 during
osteoblast diﬀerentiation with the property of defect-related luminescence. Nano-scale S2 could be
internalized by osteoblasts (OBs) via caveolae-mediated endocytosis and macropinocytosis. S2
incorporated into the lysosomes dissolved and released calcium ions for the formation of mineralized
nodules. Extracellular S2 also promoted bone regeneration as a nucleation site. Taken together, the
physical properties of hydroxyapatite control the bone regeneration pathway in osteoblasts.Introduction
Hydroxyapatite (HAP) is the major mineral component of
calcied tissues. Synthetic HAP (Ca10(PO4)6(OH)2) has been
extensively used as an implant material for bone substitutes due
to its biocompatibility, bioactivity and osteoconduction prop-
erties.1–3 To monitor the biological relevant testing of HAP, it is
desirable to develop uorescent labeled nanoparticles for
tracing. However, traditional HAP generally exhibits no lumi-
nescence, which seriously limits its applications. To overcome
this limitation, uorescent HAP nanoparticles doped with rare
earth ions (e.g., Eu3+ and Tb3+) and organic dyes have been
developed and applied in the bioimaging eld.4–6 However, the
introduction of these doped ions and organic dyes may aﬀect
the mineralization of bone cells, which is unsuitable for
studying the eﬀects of HAP on bone regeneration. Thus, it is
necessary to develop novel luminescent HAP without intro-
ducing rare earth ions and uorescent dyes.
Defect-related luminescent materials do not contain any
transitionmetal or rare earth activators, and the emission arises
from special defects.7 These materials were earlier reported in
19868 and have achieved remarkable development since the
synthesis of white phosphors from a silicate-carboxylate sol–gel
precursor.9 The defect-related luminescent materials can bent Chemistry of Ministry of Education,
8, P.R. China. E-mail: zhulinhua1981@
wick, Coventry, CV4 7AL, UK. E-mail: d.m.
hemistry 2019used in various electronics-related applications due to the
advantages of low toxicity and stability.10,11 In our previous
work, three defect-related luminescent hydroxyapatite particles
with diﬀerent morphologies and sizes were synthesized. The
defect-related luminescent HAP materials in the nano-scale
show excellent biocompatibility in biomedical applications.12
The defect-related luminescent materials are nontoxic for
osteoblasts. Previous studies have reported that the materials
modied with HAP tend to improve the mineralization of bone
cells.13 Thus, we want to know whether the defect-related
luminescent HAP materials have any eﬀects on bone
regeneration.
In this current work, by taking advantage of the defect-
related luminescence properties, an evaluation of the HAP
nanoparticles on the subcellular location and their inuence on
the bone regeneration of osteoblasts was carried out systemat-
ically. This work is quite diﬀerent from our previous work, and
it is an extension of the last work.Materials and methods
Materials
Newborn (1–2 days old) ICR mice were purchased from the
Experimental Animal Center of Hebei Medical University.
DMEM was purchased from Gibco-BRL (Grand Island, NY,
USA). Neonatal bovine serum (NBS) was obtained from Hang-
zhou Sijiqing Biological Engineering Materials Co., Ltd.
(Hangzhou, China). Trypsin, benzylpenicillin, streptomycin, b-
glycerphosphate, ascorbic acid, dexamethasone, sirius red,
picric acid, alizarin red S (ARS), cetylpyridinium-chloride,RSC Adv., 2019, 9, 35939–35947 | 35939
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View Article Onlinepropidium iodide (PI) and acridine orange (AO) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Mito-Tracker Green,
Lyso-Tracker Red, and wortmannin were purchased from
Beyotime Institute of Biotechnology (Haimen, China). Nystatin
was purchased from Aladdin (Shanghai, China). Chlorproma-
zine hydrochloride was purchased from TCI (Tokyo, Japan). An
ALP activity kit and a micro-protein assay kit were obtained
from Nanjing Jiancheng Biological Engineering Institute
(Nanjing, China). TRIzol reagent was purchased from Invi-
trogen (Carlsbad, CA, USA) The Revertaid First Strand cDNA
Synthesis Kit was purchased from Thermo Scientic (Vilnius,
Lithuania). UltraSYBR mixture was purchased from Beijing
ComWin Biotech Co., Ltd. (Beijing, China). All the other
chemicals were of analytical grade and used without further
purication.Synthesis of HAP
A defect-related luminescent HAP sample was synthesized as
previously reported.12 Ca(NO3)2$4H2O and hexadecyl-
trimethylammonium bromide (CTAB) were dissolved in deion-
ized water, and the pH was adjusted to 7.0 using HNO3 or
NH3$H2O solutions. Subsequently, a “mixing solution” con-
taining trisodium citrate and (NH4)2HPO4 was added to the
above solution. Aer stirring for 20 min, the mixture was
transferred into an autoclave, sealed, and maintained at 180 C
for 24 h. Precipitates were washed with deionized water and
absolute ethanol and then air-dried at room temperature. The
HAP sample prepared at pH 7.0 was labeled as S2.Characterization
The morphology of S2 was determined using a JSM-7500 F cold
eld scanning electron microscope (SEM) (JEOL, Japan) and an
FEI Tecnai G2 S-Twin transmission electron microscope (TEM)
(FEI, America). The chemical structure was characterized by
a Bruker Advance D8 X-Ray diﬀractometer (XRD) (Bruker, Ger-
many). Photoluminescence (PL) spectra of S2 were tested by
a Hitachi F-7000 spectrophotometer.Isolation and culture of primary OBs
Primary OBs were isolated from neonatal mouse calvaria by
sequential digestion with trypsin and collagenase as described
previously.12 All studies involving the use of animals were con-
ducted in conformity with NIH guidelines (NIH Publications
No. 8023, revised 1978) and were approved by Animal Care and
Use Committee of Hebei Medical University. Briey, calvaria
were isolated aseptically from neonatal ICR mice. Aer elimi-
nating all so tissues, the calvaria were digested once with
0.25% trypsin for 25 min and twice with 0.1% collagenase II for
1 h each. The cells were collected and cultured in a 75 cm2 ask
with complete medium (DMEM containing 10% NBS, 100 U
mL1 penicillin, and 100 mg mL1 streptomycin) at 37 C under
a humidied atmosphere with 5% CO2. The medium was
changed every 3 days.35940 | RSC Adv., 2019, 9, 35939–35947In Vitro cell uptake
The uptake of S2 was performed according to the method
described by Amornwachirabodee et al.14 In brief, OBs were
seeded in a 35 mm glass bottom dish at the density of 4  104
cells per well and allowed to adhere overnight. Cells were
incubated with S2 at 37 C under a humidied atmosphere with
5% CO2 for 24 h. The media were removed, and the cells were
washed thrice with PBS; then, the cells were stained with 6 mg
mL1 acridine orange (AO) for 30 min in the dark. Then, the
media were removed, and the cells were washed thrice with PBS
before being subjected to confocal laser scanning microscopy
(CLSM) (Olympus FV1000, Japan). Excitation at 488 nm and
uorescence signals at 580–680 nm were collected as AO uo-
rescence signals. Excitation at 405 nm and uorescence signals
at 415–515 nm were collected as S2 uorescence signals. Images
indicating the locations of S2 were then constructed using the
overlap signals.Inhibition of endocytosis
The endocytotic pathways were performed according to the
method described by Greulich et al.15 In brief, OBs were seeded
in 6-well plates at the density of 1  105 cells per well and
allowed to adhere overnight. OBs were treated with inhibitors of
endocytosis (3.5 mM chlorpromazine hydrochloride, 5 mM
nystatin or 200 nM wortmannin) for 30 min at 37 C under cell
culture conditions. Then, OBs were washed twice with PBS and
changed for a new complete medium. Aer this pretreatment,
S2 was added to the culture (nal concentration: 80 mg mL1)
and the cells were incubated for a further 1 h. Cells treated
without inhibitors were set as the control. OBs incubated with
S2 were set as a positive control, and the cells incubated without
S2 were set as a negative control. Subsequently, the cells were
harvested and resuspended in PBS. The uptake of particles into
OBs was analyzed by a ow cytometer (FACSCalibur, Becton
Dickinson). The side scatter data were analyzed using the
CellQuest soware. Calibration reagents and solutions for ow
cytometry were obtained from Becton Dickinson. Aer
achieving the appropriate instrument settings and compensa-
tions, the instrument setup was not changed throughout the
study. Ten thousand cells were acquired for each measurement.Subcellular location of S2
The co-localization studies were performed according to the
method described by Greulich et al.15 OBs were cultured as
described above and exposed to 80 mg ml1 S2 particles for 24 h.
Following incubation, the OBs were labeled with specic cell
organelle uorescent probes (Beyotime). In order to label the
lysosomes and mitochondrion, the cells were incubated with
75 nM Lyso-Tracker Red and 100 nM Mito-Tracker Green in
complete medium for 45 min at 37 C. CLSM was taken
(FV1000, Olympus) and processed using the FV10-ASW so-
ware. To label the cell nucleus, the cells were xed with 4%
paraformaldehyde for 10 min, followed by permeabilization
with 0.2% Triton X-100 in PBS for 2 min. Then, the cells were
incubated with 100 mg mL1 PI in complete medium for 30 minThis journal is © The Royal Society of Chemistry 2019
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
14
/2
01
9 
2:
32
:2
6 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineat 37 C. Aer three rinses in PBS, the cells were viewed under
CLSM (Olympus).
Collagen production analysis
The Sirius red staining–based colorimetric assay was used to
quantify collagen deposition. Collagen production analysis was
performed according to the method described by Walter et al.16
OBs were seeded in 48-well tissue culture plates at the density of
1  104 cells per well with OS. S2 at a nal concentration of 80
mg mL1 was added to complete medium and incubated for 14
d. OBs treated with only OS were used as the control group. The
plates were washed three times with ice-cold PBS and xed for
1 h with 10% formaldehyde and washed with triple-distilled
water. Then, 200 mL of dye solution (1 mg Sirius red was dis-
solved in 1 mL saturated solution of picric acid) per well was
added and incubated for 1 h. Aer that, plates were washed with
0.01 M HCl to remove the excess of the dye solution. The
collagen xed with dye was extracted with 200 mL of 0.1 M NaOH
solution per well. OD was measured by a microplate spectro-
photometer at 550 nm. All results were normalized by the
protein content. The collagen production rate (%) was calcu-
lated using the following formula: (ODtreated  ODblank)/
(ODcontrol  ODblank)  100.
Mineralized matrix formation assay
An ARS staining assay was used to evaluate mineralized matrix
formation, as described in detail elsewhere.17 OBs were seeded
in 48-well culture plates at the density of 1  104 cells per well
with the osteogenic induction supplement (OS) containing 0.1
mM dexamethasone, 5.0 mM b-glycerophosphate and 50 mg
mL1 ascorbic acid. The medium was changed to diﬀerentia-
tion medium OS in the presence or absence of S2 at the
concentrations of 20, 40 and 80 mg mL1 for 17 d. OBs treated
with only OS were used as the control group. Aer incubation,
the cells were xed in 95% ethanol for 10 min at room
temperature. The xed cells were washed with PBS and stained
with ARS (40 mM) for 30 min at 37 C. Quantitation of ARS
staining was performed by elution with 10% (w/v) cetylpyr-
idinium chloride 200 mL per well at room temperature for
20min. OD wasmeasured by amicroplate spectrophotometer at
570 nm. All results were normalized by the protein content. The
mineralized rate (%) was calculated using the following
formula: (ODtreated  ODblank)/(ODcontrol  ODblank)  100.
Real-time RT-PCR
The quantitative messenger RNA (mRNA) expression of runt-
related transcription factor 2 (RUNX2) and osteocalcin (OCN)
was characterized by real-time reverse transcriptase polymerase
chain reaction (RT-PCR) (ABI Stepone Plus, USA). Aer 14 days
of culture, total RNA was extracted using the TRIzol reagent
according to the manufacturer's instructions. The quality and
concentration of RNA samples were detected using a spectro-
photometer (Bio-Rad Smartspec Plus, USA) at 260, 280 nm
absorbance and calibrated by DEPC water. cDNA was reverse
transcribed using the Revertaid First Strand cDNA Synthesis Kit.
The resultant cDNA was used for the PCR reaction using theThis journal is © The Royal Society of Chemistry 2019UltraSYBR mixture. Reaction conditions were 95 C for 15 s,
60 C for 30 s and 72 C for 30 s. Three independent cultures
were analyzed. Gene expression was normalized by glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) using a comparative
cycle threshold (DDCt) method. Primer pairs used were as
follows: GAPDH forward: 50-GAC TTC AAC AGC AAC TCC CAC-
30, reverse: 50-TCC ACC ACC CTG TTG CTG TA-30; OCN forward:
50-GAA CAG ACT CCG GCG CTA-30, reverse: 50-AGG GAG GAT
CAA GTC CCG-30; RUNX2 forward: 50-TTC TCC AAC CCA CGA
ATG CAC-30, reverse: 50-CAG GTA CGT GTG GTA GTG AGT-30.
Nucleation role of S2 in the formation of the mineralized
matrix
ARS staining assay was used to stain the mineralized matrix, as
described above. In brief, cells were seeded in a glass coverslip
at 2  104 cells per mL and cultured for 24 h. Aer treatment
with OS in the presence or absence of S2 (80 mg mL1) for 17 d,
cells were stained with ARS as described above. The cells were
washed three times with PBS. The mineralized matrix was
detected by a uorescence microscope (Olympus BX53, Japan)
with an excitation of 395–410 nm and an emission of 450–
470 nm for S2 to trace the fate of HAP.
Statistical analysis
Data were collected from three separate experiments. The
results were expressed as mean  standard deviation (SD). The
statistical diﬀerences were analyzed using SPSS0 t-test. P < 0.05
was considered to indicate statistical diﬀerences.
Results and discussion
Characterization of S2
In our experiments, defect-related luminescent hydroxyapa-
tite particles S2 were synthesized according to our previously
reported method, in which the fabrication process has been
described in detail. Sample S2 particles were formed as
nanorods (Fig. 1a and b). The diameter and length of S2 were
approximately 25 nm and 100 nm, respectively. Fig. 1c shows
that the diﬀraction peaks of S2 can be well indexed to the
hexagonal phase HAP (JCPDS card no. 09–0432). The PL
excitation and emission spectra (Fig. 1d) of the S2 nanorods
display broad bands centered at 339 and 418 nm,
respectively.
Uptake and mechanism of S2 in OBs
Nanophase HAP possesses unique properties and many
researchers have found that the HAP nanoparticles can easily
enter many types of cells.18,19 Strong blue uorescence was
observed inside the OBs incubated with nano-scale S2 for 24 h
(Fig. 2). Furthermore, most of the uorescence signals were
within the cytoplasm. It could be conrmed that the S2 nano-
rods entered OBs.
In order to analyze the mechanism of the cellular uptake of
nano-scale HAP, selective inhibitors of the specic routes of
endocytosis were applied. OBs were preincubated for 30 min
with individual inhibitors; then, S2 (80 mg mL1) was added andRSC Adv., 2019, 9, 35939–35947 | 35941
Fig. 1 (a) SEM image of S2. (b) TEM image of S2. (c) XRD pattern of S2. (d) PL excitation and emission spectra of S2.
Fig. 2 Evaluation of the uptake of S2 by OBs. (a–c) Control, (d–f) S2. (a and d) Blue ﬂuorescence (425–475 nm) images from S2 by excitation at
405 nmwith a semiconductor laser beam. (b and e) Red ﬂuorescence (617–717 nm) images from AO stained at 488 nmwith an argon laser beam.
(c and f) The overlap images are nanorods and cells; scale bar is 20 mm.
35942 | RSC Adv., 2019, 9, 35939–35947 This journal is © The Royal Society of Chemistry 2019
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View Article Online
Fig. 3 Uptake of S2 into OBs in the presence of diﬀerent endocytosis
inhibitors. OBs were preincubated for 30 min with the individual
inhibitors and subsequently, the S2 (80 mg mL1) uptake over 1 h was
analyzed by ﬂow cytometric light scatter analysis; the representative
scattergrams are shown.
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View Article Onlinecell culture was continued for 1 h (Fig. 3). The quantication of
the uptake of nanoparticles was performed by ow cytometry
using side scatter analysis. Compared to the result for the
negative control, the scatter signal signicantly increased in theFig. 4 Fluorescence images taken using CLSM. The cells were treated w
475 nm) from S2 on excitation at 405 nmwith a semiconductor laser beam
Tracker Green on excitation at 488 nm with an argon laser beam; (c) m
lysosomes stained with Lyso-Tracker Red on excitation at 559 nmwith a h
Scale bar is 20 mm.
This journal is © The Royal Society of Chemistry 2019treatment of S2. Furthermore, the addition of inhibitors via
clathrin-mediated endocytosis OBs treated with S2 and
a specic clathrin-mediated endocytosis inhibitor (chlorprom-
azine) showed no signicant decrease in the scatter signal. In
the presence of a specic caveolae inhibitor (nystatin) and
macropinocytosis inhibitor (wortmannin), the scatter signal
decreased (6.64% and 5.07%, respectively) in comparison to
that for OBs that were not treated with the inhibitor. Never-
theless, the inhibition of caveolae-mediated endocytosis and
macropinocytosis did not result in the complete suppression of
endocytosis. Caveolae-mediated endocytosis and micro-
pinocytosis were highly involved in the uptake of S2.Intracellular localization of internalized S2
Schmidt et al.20 found that CaP nanoshells were internalized by
cells and localized around the cell nucleus. Although research
has conrmed that the nanoparticles may internalize, the
subcellular distribution is still not clearly understood. To
determine the intracellular distribution of internalized S2, the
lysosomes and mitochondrion were labeled with a panel of
specic organelle markers. In order to demonstrate the uptake
of S2, OBs were cultured with S2 at 37 C for 24 h under cell
culture conditions. CLSM was performed on the same cell areas
(Fig. 4 and 5). The S2 nanoparticles were mainly incorporatedith S2 nanoparticles (80 mg mL1) for 24 h. (a) Blue ﬂuorescence (425–
; (b) green ﬂuorescence (500–545 nm) frommitochondria with Mito-
erged images of (a) and (c); (d) red ﬂuorescence (575–675 nm) from
elium-neon laser beam; (e) merged images of (a) and (d); (f) bright ﬁeld.
RSC Adv., 2019, 9, 35939–35947 | 35943
Fig. 5 Fluorescence images taken under CLSM. The cells were treated with S2 nanoparticles (80 mg mL1) for 24 h. (a and d) Blue ﬂuorescence
(425–475 nm) from S2 on excitation at 405 nmwith a semiconductor laser beam; (b and e) red ﬂuorescence (575–675 nm) from nucleus stained
with PI on excitation at 559 nm with an argon laser beam; (c and f) overlap. Scale bar is 20 mm.
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View Article Onlineinto the cytoplasm and not into the nucleus. As shown in Fig. 4
and 5, the S2 nanoparticles are mainly found to be associated
with lysosomes areas (Fig. 4) but not inside the mitochondrion
and the nucleus (Fig. 4 and 5). The HAP particles can be eﬃ-
ciently dissolved in the acidic intracellular compartments and
release calcium ions.21 The Ca2+ ions promote cell attachment,
growth, and diﬀerentiation.22 Higher Ca2+ concentrations
promote osteoblast diﬀerentiation, leading to bone minerali-
zation in both growth and osteogenic conditions.23,24 The HAP
particles internalized in the cells release Ca2+ and promote
mineralization through an intracellular pathway.Fig. 6 Quantiﬁcation of the mineralization in OBs cultured with S2. (A) C
after 17 days of culture. (B) The quantiﬁcation (OD) of the destained ARS
35944 | RSC Adv., 2019, 9, 35939–35947Eﬀect of S2 on the formation of mineralized nodules
A previous work has demonstrated that HAP enhances bone
regeneration.25 On day 17, S2 promoted the formation of the
mineralized nodules of OBs at all concentrations in a dose-
dependent manner (Fig. 6).Eﬀect of S2 on the synthesis of collagen of OBs
Collagen I is widely used to evaluate osteogenic diﬀerentia-
tion.26 As shown in Fig. 7, aer incubating for 14 d, S2
promotes the synthesis of collagen of OBs at the concentrationells incubated with S2 nanoparticles were stained with alizarin red (ARS)
. Scale bar is 200 mm.
This journal is © The Royal Society of Chemistry 2019
Fig. 7 Eﬀect of S2 on the synthesis of collagen of OBs. OBs were treated with S2 (80 mg mL1) for 14 d. The collagen was dyed by a Sirius red
solution and quantiﬁed by a microplate spectrophotometer at a wavelength of 550 nm. All results were normalized by the protein content. Data
are presented as mean  SD from a representative of three separate experiments performed in sextuplicate. ***P < 0.001 compared with the
control; the scale bar is 200 mm.
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View Article Onlineof 80 mg mL1. The morphologic observation was in accor-
dance with the results.Quantitative osteocalcin gene expression (RT-PCR analysis)
The results for the OCN and RUNX2 gene expression over time
are presented in Fig. 8. Aer 14 days of culture, the mRNA levels
of RUNX2 and OCN were about 1.05- and 1.15-fold higher than
that of control group, respectively. These results indicated that
S2 up-regulated the expression of OCN, while it could not
change the expression of RUNX2 under standard culture
conditions. OCN is believed to be crucial in regulating osteo-
blast activity and binding of HAP.27 Combined with our Alizarin
staining and Sirius red results, these results suggest that theFig. 8 Quantitative OCN and RUNX2 gene expressions after being
cultured with S2. Data are presented as a fold ratio after being
normalized to GAPDH values. *P < 0.05, **P < 0.01, ***P < 0.001 vs.
control, n ¼ 3.
This journal is © The Royal Society of Chemistry 2019higher expression of OCN in the HAP nanoparticle-treated
osteoblast cells stimulates more mineralization in the culture.28Nucleation role of S2 in the formation of the mineralized
matrix
Previous reports have demonstrated that a newly formed
bone can be correlated with the presence of HAP nano-
particles, which can be associated with nucleating events.29
To date, there are no reports on whether the HAP particles
promote bone regeneration intracellularly or extracellularly
and whether they act as a mineral source or a nucleation site
for mineral growth.20 The distribution of S2 in the mineral-
ized nodule is shown in Fig. 9. The mineralized nodules
produced by OBs have no luminescence, while S2 has defect-
related luminescence. By taking advantage of the uores-
cence of S2, we found that extracellular S2 is located at the
center of the mineralized nodules (Fig. 9). This result was
consistent with previous results: the presence of HAP
promoted the formation of mineralized nodules. The HAP
particles can also promote mineralization through an extra-
cellular pathway.
In summary, the S2 nanorods were uptaken by OBs through
caveolae-mediated endocytosis and macropinocytosis and
showed a positive eﬀect in regulating the expression of OCN, the
synthesis of collagen and the formation of mineralized nodules.
Intracellular S2 could be distributed in lysosomes and dissolved
and released calcium ions for the formation of mineralized
nodules. The extracellular S2 as a nucleation site promoted the
formation of mineralized nodules. The S2 nanorods promoted
bone regeneration through both intracellular and extracellular
pathways (Fig. 10).RSC Adv., 2019, 9, 35939–35947 | 35945
Fig. 9 Fluorescence imaging of mineralized nodules stained with alizarin red (ARS) after 17 days of culture. Blue, the blue light from S2 excited by
UV; red, the bright image of the mineralized nodule; merged, the distribution of S2 in the mineralized nodule, the scale bar is 50 mm.
Fig. 10 The mechanism of S2 nanorods promoting OB mineralization
through both intracellular and extracellular pathways.
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